Fingerprint
Dive into the research topics of 'A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer
Everett E. Vokes, Gary S. Gordon, Charles M. Rudin, Ann M. Mauer, Sylvia Watson, Stuart Krauss, Rose Arrieta, Harvey M. Golomb, Philip C. Hoffman
Research output: Contribution to journal › Article › peer-review
20
Scopus
citations